Arbutus Biopharma (ABUS) Selling, General & Administrative (2013 - 2026)
Arbutus Biopharma (ABUS) reported Selling, General & Administrative of $3.87 million for Q2 2026, up 16.2% from $3.33 million a year earlier but down 34.3% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arbutus Biopharma's Selling, General & Administrative came in at $16.49 million, down 10.4% year-over-year; for FY2025, it came in at $15.89 million, down 28.1% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $22.11 million in FY2024 (-1.6%), $22.48 million in FY2023 (+26.0%), $17.83 million in FY2022 (+4.1%) and $17.14 million in FY2021 (+15.4%).
- Five-year quarterly Selling, General & Administrative spans a low of $3.04 million in Q3 2025 and a high of $7.55 million in Q2 2024.
- Year over year, Selling, General & Administrative gained in three of the last eight quarters, with an average decline of 14.2%.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2023 (growth of 67.2%); the low point was Q2 2025 (a decline of 55.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.89 million (Q1 2026), $3.69 million (Q4 2025) and $3.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - | 3.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.87 Mn |
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 4.71 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.84 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.55 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 5.20 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 4.60 Mn |
| Sep 30, 2021 | 4.18 Mn |
API Access
Arbutus Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();